Results 21 to 30 of about 358,601 (360)

Booster COVID-19 vaccination against the SARS-CoV-2 Omicron variant: A systematic review

open access: yesHuman Vaccines & Immunotherapeutics, 2022
There is a wealth of data suggesting that the effectiveness of existing vaccines against the Omicron variant, the most mutated SARS-CoV-2 variant to date, has been substantially reduced if only primary vaccination is administered.
Yuxuan Du, Long Chen, Yuan Shi
doaj   +1 more source

A single mutation in the envelope protein modulates flavivirus antigenicity, stability, and pathogenesis [PDF]

open access: yes, 2017
The structural flexibility or 'breathing' of the envelope (E) protein of flaviviruses allows virions to sample an ensemble of conformations at equilibrium.
Diamond, Michael S   +4 more
core   +8 more sources

Neutralizing Antibody Response following a Third Dose of the mRNA-1273 Vaccine among Cancer Patients

open access: yesVaccines, 2023
Cancer patients are at an increased risk of morbidity and mortality from SARS-CoV-2 infection and have a decreased immune response to vaccination. We conducted a study measuring both the neutralizing and total antibodies in cancer patients following a ...
Christopher W. Dukes   +20 more
doaj   +1 more source

Detection of antibodies against H5 and H7 strains in birds: evaluation of influenza pseudovirus particle neutralization tests. [PDF]

open access: yesInfect Ecol Epidemiol, 2014
Introduction: Avian influenza viruses circulate in bird populations, and it is important to maintain and uphold our knowledge of the viral strains that are currently of interest in this context.
Wallerström S   +8 more
europepmc   +2 more sources

Safe Pseudovirus-based Assay for Neutralization Antibodies against Influenza A(H7N9) Virus

open access: yesEmerging Infectious Diseases, 2013
Serologic studies are urgently needed to assist in understanding an outbreak of influenza A(H7N9) virus. However, a biosafety level 3 laboratory is required for conventional serologic assays with live lethal virus.
Chao Qiu   +11 more
doaj   +1 more source

Seroprevalence of Flavivirus Neutralizing Antibodies in Thailand by High-Throughput Neutralization Assay: Endemic Circulation of Zika Virus before 2012

open access: yesmSphere, 2021
Neutralization tests are the most reliable assay for flavivirus antibody detection; however, these assays are not suitable for high-throughput processing due to their time-consuming and labor-intensive nature.
Atsushi Yamanaka   +11 more
doaj   +1 more source

Low seroprevalence of Zika virus infection among adults in Southern Taiwan

open access: yesBMC Infectious Diseases, 2019
Background We recently conducted a serosurvey of newly arrived workers in Taiwan from four Southeast Asian countries which revealed that 1% of the migrant workers had laboratory-confirmed recent Zika virus (ZIKV) infection. Taiwan, where Aedes mosquitoes
Yu-Wen Chien   +5 more
doaj   +1 more source

Impact of standard test protocols on sporicidal efficacy [PDF]

open access: yes, 2016
Background There has been an increase in the availability of commercial sporicidal formulations. Any comparison of sporicidal data from the literature is hampered by the number of different standard tests available and the use of diverse test ...
Criquelion, J.   +3 more
core   +1 more source

Immunological reactivity of a human immunodeficiency virus type I derived peptide representing a consensus sequence of the GP120 major neutralizing region V3 [PDF]

open access: yes, 1992
To reduce the opportunities for human immunodeficiency virus type 1 (HIV-1) to evade vaccine induced immunity, the development of subunit vaccines must focus on the characterization of immunogenic epitopes, which are major targets for the immune system ...
Böltz, T.   +6 more
core   +5 more sources

West Nile Virus Infection in Plasma of Blood and Plasma Donors, United States

open access: yesEmerging Infectious Diseases, 2009
This study investigated the association of ongoing West Nile virus (WNV) infections with neutralizing antibody titers in US plasma-derived intravenous immune globulin released during 2003–2008.
Christina B. Planitzer   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy